IMC Chicago’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.1M Buy
36,000
+3,000
+9% +$263K ﹤0.01% 2607
2026
Q1
$2.98M Sell
33,000
-1,000
-3% -$91.8K ﹤0.01% 2227
2025
Q4
$3.06M Buy
34,000
+3,400
+11% +$322K ﹤0.01% 2092
2025
Q3
$3.01M Sell
30,600
-6,100
-17% -$604K ﹤0.01% 1955
2025
Q2
$3.35M Buy
36,700
+16,800
+84% +$1.62M ﹤0.01% 1650
2025
Q1
$2.25M Sell
19,900
-8,700
-30% -$931K ﹤0.01% 1724
2024
Q4
$3.02M Buy
28,600
+11,000
+63% +$1.18M ﹤0.01% 1564
2024
Q3
$1.9M Buy
17,600
+4,100
+30% +$447K ﹤0.01% 1700
2024
Q2
$1.47M Buy
+13,500
New +$1.59M ﹤0.01% 1748

Other funds holding ZBH

IMC Chicago's ZBH Position: Q2 2026 in Review

IMC Chicago increased its Zimmer Biomet (ZBH) stake by 11% in Q2 2026, buying an estimated $59K and bringing the position to 6,787 shares worth $584K. The position accounts for ﹤0.01% of the portfolio, ranked #4462.

IMC Chicago first reported a position in ZBH in Q1 2026 and has held it in 2 quarters since. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • IMC Chicago held 6,787 shares of Zimmer Biomet worth $584K as of Q2 2026.
  • IMC Chicago bought 673 Zimmer Biomet shares in Q2 2026, an estimated $59K.
  • Zimmer Biomet made up ﹤0.01% of IMC Chicago's portfolio in Q2 2026, its #4462 holding.
  • IMC Chicago first reported a position in Zimmer Biomet in Q1 2026 and has held it in 2 quarters since.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on IMC Chicago's 13F filing for Q2 2026, filed 6 Aug 2026.